ViroTact is rated 3 out of 5 in the category biotechnology. Read and write reviews about ViroTact. ViroTact©, a subsidiary of Detact Diagnostics™, both based in the Netherlands, with UK satellite offices, is advancing with the development of a rapid, affordable, non-invasive, point of care test for Covid-19, the CoviTact©.
Company size
1-10 employees